A new obesity startup, an acquisition gone wrong, & the future of Teladoc

And it's Mohana's first appearance on the podcast!

April 19, 2024 Check out STAT+

Sponsored By

How does a startup compete with the likes of Eli Lilly and Novo Nordisk in the rapidly evolving field of weight loss drugs? And how did a major telemedicine company fall flat after its pandemic-induced rise? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. We bring on biotech veteran Clive Meanwell to discuss his new obesity startup, Metsera, and running head-to-head trials against Wegovy and Zepbound. We also dissect how Teladoc CEO Jason Gorevic parted ways with the company after spending 15 years building the telemedicine field. Listen Now Subscribe to the podcast to never miss an episode iTunes Google Spotify SoundCloud Podcast Addict TuneIn Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser